Anticoagulant activities of oleanolic acid via inhibition of tissue factor expressions

BMB Reports

Volumn 45, Issue 7, 2012, Pages 390-395

  Lee, Wonhwa ^a,b   Yang, Eun Ju ^a   Ku, Sae Kwang ^c   Song, Kyung Sik ^a   Bae, Jong Sup ^a  

^a Kyungpook National University   (South Korea)

^b Kyungpook National University School of Medicine   (South Korea)

^c Daegu Haany University   (South Korea)

Author keywords

aPTT; Coagulation cascade; Oleanolic acid; PT; Thrombin

Indexed keywords

ANTICOAGULANT AGENT; FIBRIN; OLEANOLIC ACID; THROMBOPLASTIN;

ARTICLE; CATALYSIS; CELL CULTURE; DRUG ANTAGONISM; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; METABOLISM; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY;

ANTICOAGULANTS; CATALYSIS; CELLS, CULTURED; ENZYME-LINKED IMMUNOSORBENT ASSAY; FIBRIN; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; OLEANOLIC ACID; THROMBOPLASTIN;

EID: 84866613367     PISSN: 19766696     EISSN: 1976670X     Source Type: Journal    
DOI: 10.5483/BMBRep.2012.45.7.065     Document Type: Article

References (24)

1. Kaiser, L. and Sparks, H. V. Jr. (1987) Endothelial cells. Not just a cellophane wrapper. Arch. Intern. Med. 147, 569-573.
2. Davie, E. W. (1995) Biochemical and molecular aspects of the coagulation cascade. Thromb. Haemost. 74, 1-6.
3. Chong, A. Y., Blann, A. D. and Lip, G. Y. (2003) Assessment of endothelial damage and dysfunction: observations in relation to heart failure. QJM 96, 253-267.
4. Davie, E. W., Fujikawa, K. and Kisiel, W. (1991) The coagulation cascade: initiation, maintenance, and regulation. Biochemistry 30, 10363-10370.
5. Monroe, D. M., Hoffman, M. and Roberts, H. R. (2002) Platelets and thrombin generation. Arterioscler. Thromb. Vasc. Biol. 22, 1381-1389.
6. Quinn, C., Hill, J. and Hassouna, H. (2000) A guide for diagnosis of patients with arterial and venous thrombosis. Clin. Lab. Sci. 13, 229-238.
7. Della Valle, P., Crippa, L., Garlando, A. M., Pattarini, E., Safa, O., Vigano D'Angelo, S. and D'Angelo, A. (1999) Interference of lupus anticoagulants in prothrombin time assays: implications for selection of adequate methods to optimize the management of thrombosis in the antiphospholipid-antibody syndrome. Haematologica 84, 1065-1074.
8. Furie, B. and Furie, B. C. (2005) Thrombus formation in vivo. J. Clin. Invest. 115, 3355-3362.
9. Li, S. S. (2002) Mistletoe lectins: telomerase inhibitors in alternative cancer therapy. Drug. Discov. Today 7, 896-897.
10. Kim, B. K., Choi, M. J., Park, K. Y. and Cho, E. J. (2010) Protective effects of Korean mistletoe lectin on radical-induced oxidative stress. Biol. Pharm Bull. 33, 1152-1158.
11. Yoon, T. J., Yoo, Y. C., Kang, T. B., Shimazaki, K., Song, S. K., Lee, K. H., Kim, S. H., Park, C. H., Azuma, I. and Kim, J. B. (1999) Lectins isolated from Korean mistletoe (Viscum album coloratum) induce apoptosis in tumor cells. Cancer Lett. 136, 33-40.
12. Yoon, T. J., Yoo, Y. C., Kang, T. B., Her, E., Kim, S. H., Kim, K., Azuma, I. and Kim, J. B. (2001) Cellular and humoral adjuvant activity of lectins isolated from Korean mistletoe (Viscum album colaratum). Int. Immunopharmacol. 1, 881-889.
13. Yoon, T. J., Yoo, Y. C., Kang, T. B., Song, S. K., Lee, K. B., Zher, E., Song, K. S. and Kim, J. B. (2003) Antitumor activity of the Korean mistletoe lectin is attributed to activation of macrophages and NK cells. Arch. Pharm. Res. 26, 861-867.
14. Bae, J. S. (2011) Antithrombotic and profibrinolytic activities of phloroglucinol. Food Chem. Toxicol. 49, 1572-1577.
15. Liu, J. (2005) Oleanolic acid and ursolic acid: research perspectives. J. Ethnopharmacol 100, 92-94.
16. Dzubak, P., Hajduch, M., Vydra, D., Hustova, A., Kvasnica, M., Biedermann, D., Markova, L., Urban, M. and Sarek, J. (2006) Pharmacological activities of natural triterpenoids and their therapeutic implications. Nat. Prod. Rep. 23, 394-411.
17. Sugo, T., Nakamikawa, C., Tanabe, S. and Matsuda, M. (1995) Activation of prothrombin by factor Xa bound to the membrane surface of human umbilical vein endothelial cells: its catalytic efficiency is similar to that of prothrombinase complex on platelets. J. Biochem. 117, 244-250.
18. Rao, L. V., Rapaport, S. I. and Lorenzi, M. (1988) Enhancement by human umbilical vein endothelial cells of factor Xa-catalyzed activation of factor VII. Blood 71, 791-796.
19. Ghosh, S., Ezban, M., Persson, E., Pendurthi, U., Hedner, U. and Rao, L. V. (2007) Activity and regulation of factor VIIa analogs with increased potency at the endothelial cell surface. J. Thromb. Haemost. 5, 336-346.
20. Fischer, K. G. (2007) Essentials of anticoagulation in hemodialysis. Hemodial. Int. 11, 178-189.
21. Cho, S. O., Ban, J. Y., Kim, J. Y., Jeong, H. Y., Lee, I. S., Song, K. S., Bae, K. and Seong, Y. H. (2009) Aralia cordata protects against amyloid beta protein (25-35)-induced neurotoxicity in cultured neurons and has antidementia activities in mice. J. Pharmacol. Sci. 111, 22-32.
22. Nowak, P., Zbikowska, H. M., Ponczek, M., Kolodziejczyk, J. and Wachowicz, B. (2007) Different vulnerability of fibrinogen subunits to oxidative/nitrative modifications induced by peroxynitrite: functional consequences. Thromb. Res. 121, 163-174.
23. Bae, J. S. and Rezaie, A. R. (2008) Protease activated receptor 1 (PAR-1) activation by thrombin is protective in human pulmonary artery endothelial cells if endothelial protein C receptor is occupied by its natural ligand. Thromb. Haemost. 100, 101-109.
24. Dejana, E., Callioni, A., Quintana, A. and de Gaetano, G. (1979) Bleeding time in laboratory animals. II - A comparison of different assay conditions in rats. Thromb. Res. 15, 191-197.